• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    7.09 Feb 11, 4:00PM EST
    Prev Close:7.09
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:15.45
    Beta:1.91541
    Earnings Date:Apr 22 - Apr 26 (Est.)
    Day's Range:N/A - N/A
    52wk Range:6.77 - 19.43
    Volume:0
    Avg Vol (3m):1,039,510
    Market Cap:617.26M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMGN

    Comparison

    Symbol% ChgMkt Cap
    IMGN 0.00%617.26M
    SGEN3.77B
    PFE179.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.84
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-16) :-1.44
    Quarterly EPS Est (Mar-16) :-0.32
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugates technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback